NY Times reporting on Zepbound insurance coverage

Hi, everyone. My name is Rebecca Robbins, and I'm a reporter with the New York Times. I write about prescription medications. You can learn more about what I cover here.

I'm doing some reporting on Zepbound, looking at how some people and some insurance plans prefer Zepbound instead of Wegovy or other GLP-1s for weight loss. I'm interested in interviewing people in the following categories:

• Did you specifically ask your doctor to prescribe you Zepbound instead of Wegovy or other GLP-1s for weight loss?
• Are you on an insurance plan that steers you towards Zepbound instead of Wegovy or other GLP-1s for weight loss? I'm particularly interested in insurance changes that kick in Jan. 1, 2025 where Zepbound is preferred.

If you'd like to be interviewed, you can call or text me at seven one four-478-4224, or email me at [email protected]. Thank you.